×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Assessing Medical Adherence in a Clinical Trial Setting: Challenges and Solutions
Session Chair(s)
Sarah Clifford, PhD, MSc
Senior Principal, Patient-Centered Outcomes
ICON Clinical Research, Inc, United States
This workshop will provide a dynamic environment for participants to share experiences related to medication adherence in drug development, and to learn new approaches for collecting, analyzing, and reporting adherence data.
Learning Objective : Describe the extent of challenges with medication adherence across all phases of drug development; Identify where risk of medication non-adherence with a drug may arise: initiation, implementation and discontinuation; Evaluate strategies to collect, analyze, and report medication adherence across phase 2-3 clinical trial settings.
Speaker(s)
Facilitator
Lina Eliasson, PhD
Sprout Behaviour Change Ltd, United Kingdom
Founding Director
Have an account?